175 filings
Page 8 of 9
6-K
rfq4whb2g1q6
9 Nov 17
Emerging clinical data confirms the potential for RPL554 to be an important, novel treatment for patients with COPD
12:00am
6-K
qqlku9v8s8mgghwpuu
21 Sep 17
Current report (foreign)
12:00am
6-K
2v8eql
12 Sep 17
Achieved significant and clinically meaningful additional improvement in peak lung function and faster onset-of-action when added to tiotropium
12:00am
6-K
3i9vuqku3 gu
24 Aug 17
Current report (foreign)
12:00am
6-K
ar5a3tn inftdj9f9eur
8 Aug 17
Current report (foreign)
12:00am
6-K
dxjo99
26 May 17
This Announcement Contains Inside Information for the Purposes of Article 7 of Regulation (Eu) No 596/2014
12:00am
6-K
962ipi
18 May 17
This Announcement Contains Inside Information for the Purposes of Article 7 of Regulation (Eu) No 596/2014
12:00am
6-K
tvebcloq 5co
3 May 17
Verona Pharma Announces Director Purchases and Related Party Transactions
12:00am
CT ORDER
e1upkqgmthxvzq
1 May 17
Confidential treatment order
12:00am
S-8
5h8rl0
28 Apr 17
Registration of securities for employees
12:00am
424B4
8oxut gv5ll
28 Apr 17
Prospectus supplement with pricing info
12:00am
EFFECT
01tjsbsz88b1neomqmz
26 Apr 17
Notice of effectiveness
12:00am
CORRESP
ukcbe27xclkdmbujr
26 Apr 17
Correspondence with SEC
12:00am
F-1MEF
93rzx67
26 Apr 17
Registration statement to add securities to prior F-1 registration
12:00am
EFFECT
e79pom
26 Apr 17
Notice of effectiveness
12:00am
UPLOAD
dsg62vt9 rw9g1aldg
26 Apr 17
Letter from SEC
12:00am
F-1/A
9hkz8hcojv eg83he6f
26 Apr 17
Registration statement (foreign) (amended)
12:00am
UPLOAD
sj82np1b7
24 Apr 17
Letter from SEC
12:00am
CORRESP
19j n1fjc
24 Apr 17
Correspondence with SEC
12:00am
CORRESP
4a4ilcw 8usyltnz2
24 Apr 17
Correspondence with SEC
12:00am